Searched for
JUVENILE IDIOPATHIC ARTHRITIS
Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...- Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...
- Biocon Biologics launches product for autoimmune diseases in AustraliaBiocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating autoimmune di...
- Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global marketsLupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants...
- New study reveals link between rheumatic diseases and reproductive problemsA recent study published in the journal Rheumatology reveals that rheumatic diseases, such as autoimmune disorders affecting joints, muscle...
- Arthritis isn't curable. Quit smoking, manage blood glucose & exercise for 30 mins daily to delay onsetIn total, there are more than 100 different types of arthritis.
- Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in JapanMumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...
- Zydus Cadila launches biosimilar of AbbVie's Humira in IndiaZydus Cadila today launched biosimilar of Adalimumab, used for treatment of auto immune disorders, at a price much lower than the innovator...
- Cipla launches biosimilar for rheumatic disorders in IndiaDrug major Cipla said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in ...
Load More
